Saad F, Hussain MHA, Tombal B, Fizazi K, et al. Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of Eur Urol 2024 Apr 20:S0302-2838(24)02264-4. doi: 10.1016/j.eururo.2024.
PMID: 38644146